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Abstract
Bone cements are primarily used for fixation of implants as well as dampening of mechanical
loads between the implant and neighboring bone. Two-solution bone cements offer a variety of
advantages over commercial powder-liquid compositions due to a reduction in porosity, which in
turn leads to improved mechanical properties. The effectiveness of the material is limited by its
mechanical properties due to a large mismatch in moduli and strength between the cement, bone,
and implant. Two-solution bone cements modified with ethylene glycol-dimethacrylate (EGDMA) as a crosslinker have been developed as an attempt to further improve the mechanical and
thermal properties of the material. The crosslinker replaces a volumetric portion of the methyl
methacrylate (MMA) monomer and the resulting mechanical, thermal and viscous properties
were compared to a formulation free of EG-DMA.
The result of this study shows that EG-DMA can increase the mechanical properties and
fractional monomer conversion without significantly (p<0.05) affecting the thermal
characteristics, including maximum polymerization temperature and setting time. The maximum
flexural strength and bending modulus increase with increasing EG-DMA concentrations up to
10 vol% EG-DMA, and then decrease following a second order polynomial fit. The critical stress
intensity factor increases up to 5 vol% and then decreases with increasing EG-DMA content, and
the yield strength increases up to 15 vol% EG-DMA. These results indicate that up to a certain
concentration, EG-DMA vol% has more of an effect on a specific mechanical property than
decreasing the MMA concentration.
All EG-DMA compositions had a higher viscosity than the control at all measurable shear rates
due to a higher polymer to MMA ratio. These formulations demonstrated an increase in ductility
and the fractured samples displayed different surface morphologies than the control samples.

Sample sets containing EG-DMA did not fracture at the upper strain limit (10%) during flexural
tests, except 10 and 15 vol% EG-DMA. The fractured EG-DMA samples exhibited evidence of
large amounts of plastic strain before failure, indicated by micro-troughs and ridge formation.
Samples containing 20 vol% EG-DMA had the highest fractional monomer conversion and
lowest residual monomer concentration. This was attributed to the high reactivity of EG-DMA
molecules in the presence of an initiator.
These formulations provide insight into the effect of substituting a crosslinker for MMA
monomer in a two-solution injection system and layout the ideal concentrations of EG-DMA for
superior mechanical or fractional monomer conversion properties.
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1. Introduction
Poly(methyl methacrylate) (PMMA) based bone cements have been used primarily in implant
fixation and joint replacements since their development in 1958 and commercialization in the
1960s (1). The cements fill the space between the bone and device, and harden in vivo through a
free radical polymerization process resulting in a strong acrylic material. The primary functions
of bone cements are to stabilize implants and provide cushioning to the bone by transferring of
mechanical loads (2). The liquid component of bone cements is methyl methacrylate (MMA), an
ester of methacrylic acid (1, 2). The liquid component also contains N-N-dimethyl-p-toluidine
(DMPT), a tertiary aromatic amine and hydroquinone (HQ), an inhibitor. The powder component
consists principally of pre-polymerized PMMA beads or PMMA based polymers and benzoyl
peroxide (BPO), an initiator (2). When the BPO and DMPT molecules are mixed, a redox
reaction occurs and produces free radicals that trigger the cascade of MMA monomer
polymerization (3). The monomer polymerizes around the PMMA beads, creating a
‘homogeneous’ network of PMMA beads surrounded by newly polymerized PMMA. While
PMMA based bone cements are considered the gold standard in implant fixation (1,2), there
exists several drawbacks that limit the effectiveness of the material.
Acrylic bone cements undergo highly exothermic reactions due to carbon-carbon double bonds
being broken during polymerization. Temperatures at the bone-cement interface can reach up to
10° above physiological temperature (37°C) (4, 5). Thermal necrosis can occur in excess of 47°C
and protein denaturation can occur at 56°C (4). Chemical necrosis is also a factor with bone
cement due to residual MMA monomer present at the surface. Monomer can also leach out of the
cement after a prolonged amount of time (6). DMPT has also been shown to have cytotoxic
effects as well (5). Residual monomer can also have adverse effects on the mechanical properties
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of the material. The concentration of residual monomer changes over time due to a slowcontinued polymerization after the initial reaction, thus slowly changing the overall molecular
and mechanical properties of the material (7).
The clinical success of bone cements is limited by poor mechanical properties, specifically
weakness in tension, shearing and fatigue resistance (2, 6). These weaknesses can lead to aseptic
loosening of the implant at either the implant-cement or cement-bone interface. Large
mismatches in moduli between the cement and surrounding bone can cause crack propagation
throughout the material and debonding of the material at the cement-bone interface (8). Cement
particles as a result of fracture can induce osteolysis at the bone-cement interface, further
loosening the implant and ultimately resulting in failure (6). Bone cement failure can also occur
from porosity. Porosity can transpire from five different sources: (I) air within the powder
components, (II) air trapped within the liquid-powder mixture during initial wetting, (III) bubble
accumulation during stirring of the bone cement system, (IV) air trapped after cement delivery
within the mixture or along the implant/bone interfaces and (V) monomer volatilization due to
heat generation during the initial curing (9). Volumetric shrinkage is another concern during the
polymerization of bone cement. When the low density monomer is converted to a polymer of
higher density, shrinkage materializes creating porosity (3). The use of difunctionalized
methacrylates such as triethyleneglycol-dimethacrylate have shown a decrease in shrinkage with
an increase in mechanical properties (10, 11).
Hasenwinkel et al. (3) developed a two-solution bone cement (TSBC) that is highly-viscous and
injectable for the purpose of joint prostheses fixation while eliminating many of the known
setbacks previously described. It was found that concentrations of BPO and DMPT significantly
affected polymerization temperatures and setting time as well as flexural properties. A molar
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ratio of 1 (BPO:DMPT) optimized the flexural strength and modulus of the cement (3). The
mixing process developed also eliminated porosity traditionally introduced in the preparation of
the material. The cement is prepared by dissolving the powder components in the liquid
monomer, mixing for 18 hours and then letting it sit upright in cold storage for 2 days (3).
Letting the cement sit in cold storage for 2 days allows any bubbles generated to rise to the top of
the material (3). Additionally, the two-solution bone cement has a shelf life up to 12 months due
to the stability of the initiator (BPO) in cold storage (4°C) (12). The TSBC was further modified
by the addition of crosslinked-PMMA microspheres and nanospheres. The crosslinked PMMA
beads do not dissolve in the monomer resulting in a higher polymer to monomer ratio. The use of
the crosslinked particles reduced the maximum polymerization temperature due to the decreased
concentration of monomer. This modification resulted in higher degrees of shear thinning, with
the nanospheres having more of an effect on the pseudoplasticity of the cement than the
microspheres. These formulations had similar mechanical properties to the standard TSBC (3),
making it a suitable candidate for vertebroplasty applications (13, 14). Additionally, grafting
PMMA brushes on the surface of the crosslinked PMMA nanospheres resulted in a larger degree
of swelling by the PMMA particles while maintaining a suitable viscosity. These alterations were
primarily aimed at three areas of improvement: (I) improving the bonding between the PMMA
beads and the polymerized cement matrix, (II) increasing the resulting molecular weight of the
cement and (III) improving the mechanical properties (13, 14).
Ethylene glycol-dimethacrylate (EG-DMA) is a biodegradable difunctional crosslinker and an
appealing material for bone cement additives because of its ability to be used as a crosslinker
between adjacent PMMA chains (15). Alves et al. and Sasaki et al. (16, 17) both found that
crosslinking PMMA chains with EG-DMA molecules increases the material’s glass-transition
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temperature and yield stress due to a reduction in molecular mobility between PMMA chains.
Min et al. reported that when PMMA chains lightly crosslinked with 1 mol% EG-DMA undergo
shear loading, the carbon backbone degree of alignment increases (15). The backbone aligns
with the direction of external loading, thus decreasing the force per area and deformation
exhibited on the main carbon bonds. This resulted in an increase in ductility in the lightly
crosslinked PMMA chains (15).
EG-DMA molecules contain twice as many double bonds as MMA molecules, and the reactivity
and heat generated during the breaking of the first double bond has been estimated to be
indistinguishable to that of MMA (18). The addition of EG-DMA to a free radical
polymerization system can also lead to the formation of other species in addition to linear
crosslinked chains. EG-DMA molecules can remain unreacted, react once (one double bond
remains unreacted) or form cyclic species (18). Yang et al. (19) studied the effects of adding
varying concentrations of EG-DMA and hydroxyethyl methacrylate (HEMA) to PMMA based
bone cements. HEMA is a monomer with one carbon-carbon double bond. HEMA and EG-DMA
decreased the Young’s modulus and polymerization time while increasing the tensile, bending
and compressive strengths, as well as the polymerization temperature. Vallo et al. (20) prepared
self-curing bone cements with crosslinked PMMA beads using two different crosslinkers with
different chain lengths: triethyleneglycol-dimethacrylate (TEGDMA) and poly(ethylene glycol)dimethacrylate (PEG-DMA) (21). The cement compositions containing the crosslinked PMMA
beads displayed a higher flexural modulus with a decrease in yield strength. SEM images
revealed a prominent bonding effect between the crosslinked beads and the polymerized PMMA
matrix (20). Zuk et al. (22) studied the effect of polymer impregnated concrete (PIC) using
methyl methacrylate (MMA) and ethylene glycol-dimethacrylate (EG-DMA) as the monomer
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constituents. Their work showed that PIC with EG-DMA increased the compressive strength and
adhesive properties, as well as the polymerization yield due to the high reactivity of EG-DMA
monomer in the presence of an initiator (BPO) (22).
2. Specific Aims
I. Modify two-solution bone cement (TSBC) with varying levels of ethylene glycoldimethacrylate (EG-DMA) crosslinker
II. Assess mechanical properties of polymerized TSBC modified with EG-DMA using threepoint bend tests and fracture toughness tests
III. Characterize real-time thermal properties of cement compositions during free radical
polymerization
IV. Measure viscosity profiles for compositions
V. Analyze fracture surfaces and morphology of fractured mechanical samples

3. Goals and Hypotheses
We hypothesize that synthesis of an injectable two-solution bone cement (TSBC) modified with
ethylene glycol-dimethacrylate (EG-DMA) will be advantageous over other materials used for
the same application because it will have increased strength and similar thermal properties. The
strength will be increased due to localized crosslinking between adjacent PMMA chains. We
predict that the thermal properties will be similar due to compositions having similar amounts of
carbon-carbon double bonds available for polymerization. The characterization and supplemental
research associated with this material will focus on measuring the mechanical properties,
recording the real-time polymerization process and the resulting properties such as residual
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monomer content and fracture morphology. All compositions of modified TSBC with EG-DMA
will be tested against a control composition containing 0 vol% EG-DMA.
We hypothesize that the viscosity will increase across all modified compositions. PMMA is not
soluble in EG-DMA and by increasing the polymer to MMA ratio, more polymer is being
dissolved in less MMA and thus creating a more dense and viscous slurry. EG-DMA is also
more viscous at ambient temperature than MMA.
We hypothesize that the addition of the crosslinker will increase mechanical properties with
increasing EG-DMA concentrations. Increasing the crosslink density of a polymer matrix
increases the modulus (15). The crosslinker will increase the material’s resistance to deformation
along the PMMA carbon backbone (15), and this will increase the strain-to-failure of the
modified cements.
We anticipate the thermal properties to be consistent and like that of the control. The double
bond ratio (DB), ratio of double bonds in the modified sample to the control sample, increases by
3% when increasing the EG-DMA concentration up to 25 vol%. The moles of monomer initially
present decreases up to 11% (25 vol%) with increasing EG-DMA concentrations (Table 4.1.1).
While there will be more double bonds available to break and release heat, there will be less total
moles available to react with one another. We predict that these relationships will have
counteracting effects on the system and not significantly change the thermal properties. EGDMA molecules are more reactive than MMA molecules (22) and therefore we anticipate that
the total fraction of monomer molecules converted will increase with increasing EG-DMA
concentrations. We also hypothesize that the glass-transition temperature (TG) will increase in the
EG-DMA formulations due to an increase in crosslink density. Increasing the crosslink density
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will reduce the chain mobility in the cured sample, which is directly related to the glasstransition temperature (15).
Finally, we hypothesize that the fracture surface morphology will be different than the control
TSBC due to the increased crosslinking. The crosslinking will alter the fracture mechanism due
to the increased strain-to-failure. We predict that because the material will be subject to
increased strain, the surfaces will display troughs and micro-sized craters along the fractured
edge (23).
4. Materials and Methods
4.1 Cements preparation
PMMA resin (Monomer Polymer) (80,000 g/mol), MMA (Aldrich), EG-DMA (Aldrich) benzoyl
peroxide (BPO) (Aldrich) and N,N-dimethyl-p-toluidine (DMPT) (Aldrich) were used as
received in all compositions. The preparation of all cements followed the technique developed by
Hasenwinkel et al. (3). Previously described two-solution bone cements (TSBCs) containing a
polymer to monomer (g:mL) ratio (P:M) of 0.9:1 developed by Hasenwinkel et al. (3) served as
the control for all experiments performed. Compositions containing EG-DMA had a fixed
polymer to liquid (g:mL) ratio (P:L) of 0.9:1 with varying MMA to EG-DMA ratios (See Table
4.1.1). The molar ratio of EG-DMA to MMA is also given in Table 4.1.1. The PMMA resin was
massed and set aside to be the polymer component for all compositions. The total MMA and EGDMA volume was split equally between two beakers, in which one contained 1.25 g of BPO and
the other contained 0.7 mL of DMPT. The BPO to DMPT (mol:mol) ratio was fixed for all
compositions at 1, and the total liquid volume was set at 100 mL for all compositions. The MMA
solutions were mixed thoroughly to ensure complete dissolution of the BPO powder and DMPT
liquid. The two solutions were then transferred to two polypropylene cartridges followed by the
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addition of the polymer resin. The cartridges were sealed, shaken by hand for 5 minutes and
transferred to a rotating drum mixer for 18 hours at room temperature.
Table 4.1.1: Sample compositions by volume percentage, volume ratio, moles, molar ratio,
and double bond (DB) ratio between the control and modified compositions
EG-DMA
vol%
MMA
vol%
EG-DMA:
MMA
(mL:mL)
EG-DMA
moles
MMA
moles
Total
moles
EG-DMA
mol%
DB Ratio

Control

2.5EGDMA

5EGDMA

10EGDMA

15EGDMA

20EGDMA

25EGDMA

0

2.5

5

10

15

20

25

100

97.5

95

90

85

80

75

0

0.03

0.05

0.11

0.18

0.25

0.33

0

0.0132

0.0265

0.0530

0.0795

0.1060

0.1325

0.9388

0.9153

0.8919

0.8449

0.7980

0.7510

0.7041

0.9388

0.9286

0.9184

0.8979

0.8775

0.8571

0.8367

0

1.42

2.88

5.90

9.06

12.4

15.8

1.000

1.003

1.006

1.012

1.019

1.025

1.032

After mixing, cartridges were removed and stored upright at 4°C for 48 hours before use.
Volumetric ratios (mL:mL) of MMA to EG-DMA ranged from 100:0 to 75:25. Compositions
used for viscosity tests were prepared the same with the exception of the BPO and DMPT
components. This was to prevent the cement from polymerizing in the viscometer testing
chamber. Viscosity samples were also prepared in smaller cartridges using the same proportions
as above. This was due to the small size of the testing chamber. Cartridges were stored upright to
allow any bubbles generated in the mixing process to rise to the top, thus eliminating a source of
porosity during the curing process.
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4.2 Exothermal properties of cements
The maximum polymerization temperatures and setting times of the modified TSBCs were
measured using the ASTM standard F451 (25) and an in-house thermocouple sensing unit. The
thermocouple wire was soldered to create one point of contact, and the tip of the soldered wire
was placed so it was directly in the center of the mold, both vertically and concentrically. All
measurements were compared to the control TSBC. The maximum polymerization temperature
is defined as the peak temperature during the initial curing after injection into the mold. Setting
time (Figure 4.2.1) corresponds to the time at which the average temperature between ambient

Figure 4.2.1: Exothermal experimental output. Experiment begins when the cement first
mixes in the nozzle and ends after a vertex temperature has been recorded. The setting time is
defined as the time corresponding with half of the ambient temperature added to the
maximum polymerization temperature. The above figure is for the control TSBC.

10
(23±1°C) and peak temperature is reached (25). Each composition was tested in triplicate (n=3)
and reported as an average with data points taken at every 0.5 seconds. Tests began when the
cement first started mixing in the nozzle. The pneumatic gun forced the material into the mold
and the mold was screwed closed after it was filled completely. Tests ceased after the maximum
temperature was reached and the material began to cool. The polyethylene molds were cleaned
and cooled to ambient temperature after each trial. Average maximum polymerization
temperatures and setting times were reported and standard deviations were calculated.
4.3 Viscosity measurement
The viscosities of the modified TSBCs and control TSBC were measured using a digital
rotational viscometer (Brookfield Viscometer DV-E) with a coaxial spindle (SC4-14). The
viscometer was calibrated before measurements were taken using 60,000 cP (60 Pa·s) silicone oil
calibration standards (Brookfield Engineering Laboratories Inc.) to ensure accurate readings
within +/- 1% of the machine’s sensitivity. Viscosity tests were performed at ambient
temperature with the sample cartridges sitting out for a minimum of 3 hours prior to testing.
Materials were injected into the sample chamber until the chamber was 3/4 full. The chamber
then slid up into the viscometer with the spindle attached, and material was injected around the
spindle until the chamber was full. The top of the chamber was covered with aluminum foil to
prevent volatilization of the material. Rheological measurements were performed at increasing
rotational speeds (0.3 to 100 RPM) and recorded at all readings between the lower and upper
torque limits (10%≤ Torque ≤100%). Measurements were taken every 30 seconds for 5 minutes
at each RPM, and each composition was tested using the same spindle (SC4-14). Shear rate is
proportional to speed for a given spindle and the RPM was multiplied by a correction factor
based on spindle+chamber geometry used (x 0.4 for SC4-14). Compositions were tested three
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times at increasing shear rates and average viscosities and standard deviations of all trials were
reported. The spindle and viscometer chamber were cleaned in between each trial to ensure all
previous material had been removed.
4.4 Fracture toughness
Fracture toughness tests were performed per ASTM standard E399-83 (26) for plain-strain mode
I failure of at least four bone cement samples for each composition. Materials were injected into
rectangular polyethylene molds and allowed 30 minutes to polymerize. After the initial
polymerization, samples were stored in the lab at room temperature overnight and wet polished
the next day using 240, 320, 400 and 600 µm grit sandpaper. Finished samples were polished on
all sides in a uniform direction. This was to ensure consistent flat surfaces. The polyethylene
mold had an average width of 11.5 mm and average thickness of 3.25 mm, and polishing resulted
in samples having slightly smaller measurements. After polishing, a notch was made in each
sample using a slow speed diamond cut-off wheel (Buehler, Isomet Low Speed Saw) and a sharp
crack tip was made using a razor blade and a hammer. The length of each crack (a) (including
the sharp crack tip) was between 0.45W≤ a ≤0.55W where W is the sample width. Cracks were
made at the midway point of the sample length. The samples were tested at room temperature on
a Sintech MTS system (model 2GT) using a crosshead speed of 2.54 mm/min. The span length
between the machine fixtures measured 40 mm with the crosshead beam placed at the center
above the sample. Mode I plane strain fracture toughness was calculated using Equation 4.4.1:
𝑎

𝑃𝐿

𝐾𝐼𝐶 = 𝑏𝑊 3/2 ∗

𝑎

𝑎

𝑎

𝑎2

3( )1/2 [1.99−( )(1− )∗(2.15−3.93 +2.7 2 )]
𝑊
𝑊
𝑊
𝑊
𝑊
𝑎
𝑊

𝑎
𝑊

2(1+2 )(1− )3/2

(4.4.1)

where 𝐾𝐼𝐶 is the critical stress intensity factor (MPa√m), P is the maximum load (N), L is the span
length (mm), b is the sample thickness (mm), W is the sample width (mm) and a is the crack length
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(mm). The critical stress intensity factor or fracture toughness was reported as an average for each
sample set with calculated standard deviations.
4.5 Flexural properties
Three point flexural tests were performed using ASTM D790-86 standards (27) for five samples
of each composition. The samples were polymerized and wet-polished using the same procedures
as the fracture toughness tests (Section 4.4). Samples were tested using a Sintech MTS system
(model 2GT) with a crosshead speed of 2.54 mm/min and a span support length of 40 mm.
Equations 4.5.1-4.5.3 were used to calculate maximum stress (σ), flexural modulus (𝐸𝑏 ), and
maximum strain (ε).
3𝑃𝐿

𝜎 = 2𝑏𝑑2
𝐿3 𝑀

𝐸𝑏 = 4𝑏𝑑3
𝜀=

6𝐷𝑑
𝐿2

(4.5.1)
(4.5.2)
(4.5.3)

where P is the maximum load (N), L is the span support length (mm), M is the slope of the
load/crosshead displacement curve (N/mm), b is the sample width (mm), d is the sample thickness
(mm) and D is the maximum deflection measured by the crosshead beam (mm). Yield stress was
calculated by determining the equation of the elastic deformation section of the stress-strain curve,
and then applying an offset of 0.2% and determining where the offset linear equation (Equation
4.5.4) intercepted the raw data.
𝜎𝑌𝑖𝑒𝑙𝑑 = (𝐸𝑠 𝑥 + 0.002) + 𝑦𝑜

(4.5.4)

where 𝐸𝑠 is the slope of the linear region of the 𝐸𝑏 data (~0 and 1.5% strain), 𝑥 is the sample strain
data (Equation 4.5.3) and 𝑦𝑜 is the y-intercept. The slope and y-intercepts were calculated using a
linear regression model in Excel (Microsoft). The yield stress is found when Equation 4.5.4
subtracted from Equation 4.5.1 is equal to zero. Maximum flexural stress, bending (flexural)
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modulus, yield stress and strain-to-failure were reported as averages for sample sets and standard
deviations were calculated.
4.6 DSC technique
All differential scanning calorimetry experiments were performed under isothermal conditions at
50°C. Following isothermal testing, the sample chamber was ramped from 50°C to 150°C at a
heating rate of 10°C/min. All trials were performed using a TA Q200 differential scanning
calorimeter (TA). The DSC generates the data in W/g, therefore accurate readings require the mass
of the sample beforehand. The heating rate (10°C/min) was chosen based off previous observations
in the literature and in the Hasenwinkel lab (14). At lower heating rates (< 5°C/min), there exists
limitations in capturing the complete methyl methacrylate conversion of the free radical
polymerization (28). Samples were taken out of cold storage for 3 hours prior to testing and
allowed to heat up to room temperature. It was necessary to perform the experimental set-up in as
little time as possible (< 2 minutes) to ensure the machine captured the entire curing exotherm
during the onset of polymerization. Hermetic pans and lids were massed before injection and
recorded. Hermetic pans were chosen because the sample’s material properties changed
throughout the course of the experiment due to the volatile properties of the methyl methacrylate
monomer (29). Samples approximately 30-40 mg were injected into the pans through a static
mixing nozzle and the pans were hermetically sealed with the aluminum lid immediately. Samples
were remassed and the mass of the sample was calculated by subtracting the empty pan+lid mass
from the new injected mass. The samples were then placed in the DSC chamber alongside an
empty reference pan+lid and the experimental protocol began. Samples were held isothermally at
50°C for one hour followed by one heating cycle, one cooling cycle and a second heating cycle.
All non-isothermal cycles were heated and cooled at a rate of 10°C/min with heating cycles
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increasing from 50°C to 150°C and the cooling cycle decreasing from 150°C to 50°C. There was
also an isothermal hold at the end of each non-isothermal cycle for 2 minutes before the next cycle
began. This was to allow the material to stabilize at the upper and lower temperatures before the
next cycle began. Markers were placed at the end of all isothermal and non-isothermal cycles for
analysis purposes. Table 4.6.1 describes the method file used for all DSC experiments.
Table 4.6.1: Method file for isothermal and non-isothermal DSC
Method File
Jump to 50.00 °C
Isothermal for 60.00 min
Mark end of cycle 1
Ramp 10.00 °C/min to 150.00 °C
Isothermal for 2.00 min
Mark end of cycle 2
Ramp 10.00 °C/min to 50.00 °C
Isothermal for 2.00 min
Mark end of cycle 3
Ramp 10.00 °C/min to 150.00 °C
Isothermal for 2.00 min
Mark end of cycle 4

The isothermal steps are marked in blue and the non-isothermal steps of the method file are marked
in red in Table 4.6.1. The temperature ramps were performed for two fundamental reasons: (I) to
‘drive’ the reaction to completion by converting residual monomer that is either vitrified or lacks
nearby free radicals and (II) to observe the glass-transition temperature in the final cured sample
(29). The first non-isothermal scan will reveal a small peak (Figure A.1) that represents the residual
monomer. This exothermic peak is not present in the second non-isothermal scan and thus the
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inflection point, signifying the onset of molecular motion (glass-transition temperature) (24), can
be measured (Figure A.2). Setting time could not be measured due to the nature of this experiment
but the heat of reaction, degree of conversion, residual monomer concentration and glass-transition
temperature were all measured or calculated. Samples were tested in triplicate. Averages were
reported and standard deviations were calculated.
4.7 Calculation of monomer conversion parameters
The heat of reaction, also referred to as the change in enthalpy, can represent both exothermic and
endothermic processes. Exothermic processes are a release of heat while endothermic processes
take in or absorb heat (24). The power recorded (W/g) during the first hour of the isothermal DSC
scan can be integrated and transformed into exothermal heat per mole (kJ/mol), and compared to
known heats of reaction for methyl methacrylate (56.9 kJ/mol MMA) (21, 30). The DSC uses the
reference pan to accurately match the temperature of the reference pan to that of the sample pan.
As the temperature of the sample pan increases during curing, the machine adds heat to the
reference pan to match the sample pan heat, thus generating a heat flow. When the sample pan no
longer produces heat after the initial polymerization peak, the free radical reaction is over or fell
below the detection capability of the machine. After each trial was completed, each curve was
individually analyzed by integrating the power versus time for a period up to one hour. This
integral represents the total heat given off during the initial polymerization of the bone cement and
each composition was tested in triplicated. Compositions were prepared using the same material
proportions as Section 4.1, but in smaller cartridges and smaller static mixing nozzles due to the
size of the hermetic pans. The first step in analyzing the DSC data is normalization of the
exothermal curve using Equation 4.7.1.
𝑃(𝑡) = [𝐴𝑃(𝑡) − 𝐴𝑃(𝑒𝑛𝑑𝑡𝑖𝑚𝑒)]

(4.7.1)
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where P is the normalized power (W/g), AP is the power (W/g) and t is the time domain. The
power value at the end of the isothermal process represents the baseline and this value is subtracted
from all values for individualized baselines (Figure A.1). To estimate the total heat generated
during polymerization, a power-time function was applied to all integrated data. The algorithm in
Equation 4.7.2 was used to perform this function.
𝐻𝑐𝑢𝑚𝑢𝑙𝑎𝑡𝑖𝑣𝑒 = ∑𝑛−1
𝑛=0 {

𝑃𝑛+1 +𝑃𝑛
2

×(𝑡𝑛+1 − 𝑡𝑛 )}

(4.7.2)

where 𝐻𝑐𝑢𝑚𝑢𝑙𝑎𝑡𝑖𝑣𝑒 is the cumulative heat of polymerization (J/g), P is the normalized power (W/g)
and t is the time domain (s). The total heat (𝐻𝑐𝑢𝑟𝑖𝑛𝑔 ) (kJ/mol) generated is calculated using
Equation 4.7.3 using the correction factor in Equation 4.7.2.
𝐻𝑐𝑢𝑟𝑖𝑛𝑔 =

𝑀𝑊𝑀𝑀𝐴 ∗𝑀𝑓𝑀𝑀𝐴 +𝑀𝑊𝐸𝐺−𝐷𝑀𝐴 ∗𝑀𝑓𝐸𝐺−𝐷𝑀𝐴
𝑓

𝑃𝑛+1 +𝑃𝑛

∑𝑛−1
𝑛=0 {

2

×(𝑡𝑛+1 − 𝑡𝑛 )}

(4.7.3)

where 𝑀𝑊𝑀𝑀𝐴 and 𝑀𝑊𝐸𝐺−𝐷𝑀𝐴 are the molecular weights (g/mol) of MMA and EG-DMA
monomer, respectively, 𝑀𝑓𝑀𝑀𝐴 and 𝑀𝑓𝐸𝐺−𝐷𝑀𝐴 are the mass fractions for MMA and EG-DMA of
the total liquid monomer mass used and f is the mass fraction of MMA + EG-DMA in the sample.
Multiplying the molecular weights by the corresponding mass fraction used for each monomer
created a theoretical weight average molecular weight for the sample tested (24). A correction
factor was incorporated into the calculations due to the changing amount of double bonds present
between EG-DMA concentrations. This was calculated using Equation 4.7.4.
𝐷𝐵𝑓 =

𝐷𝐵𝑛
𝐷𝐵0

(4.7.4)

where 𝐷𝐵𝑓 is the double bond correction factor, 𝐷𝐵0 is the amount of double bonds present in the
TSBC control assuming 100 mL of MMA monomer, and 𝐷𝐵𝑛 is the amount of double bonds
present in the composition tested assuming 100 mL of total liquid monomer. 𝐷𝐵0 was determined
using Equation 4.7.5.
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𝐷𝐵0 =

100 𝑚𝐿∗𝜌𝑀𝑀𝐴
𝑀𝑊𝑀𝑀𝐴

∗

6.022×1023 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
𝑚𝑜𝑙𝑒

1 𝑑𝑜𝑢𝑏𝑙𝑒 𝑏𝑜𝑛𝑑

∗ 𝑀𝑀𝐴 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒 = 5.6538×1022 𝑑𝑜𝑢𝑏𝑙𝑒 𝑏𝑜𝑛𝑑𝑠 (4.7.5)

where 𝜌𝑀𝑀𝐴 is the density of the methyl methacrylate (g/mL). 𝐷𝐵𝑛 was calculated using a similar
equation, with the inclusion of the EG-DMA component.
𝐷𝐵𝑛 = [

𝑉𝑀𝑀𝐴 ∗𝜌𝑀𝑀𝐴
𝑀𝑊𝑀𝑀𝐴

∗

6.022×1023 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠
𝑚𝑜𝑙𝑒

6.022×1023 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠

1 𝑑𝑜𝑢𝑏𝑙𝑒 𝑏𝑜𝑛𝑑

∗ 𝑀𝑀𝐴 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒] + [

2 𝑑𝑜𝑢𝑏𝑙𝑒 𝑏𝑜𝑛𝑑𝑠

∗ 𝐸𝐺−𝐷𝑀𝐴 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒]

𝑚𝑜𝑙𝑒

𝑉𝐸𝐺−𝐷𝑀𝐴 ∗𝜌𝐸𝐺−𝐷𝑀𝐴
𝑀𝑊𝐸𝐺−𝐷𝑀𝐴

∗

(4.7.6)

where 𝑉𝑀𝑀𝐴 and 𝑉𝐸𝐺−𝐷𝑀𝐴 are the respective volumes of MMA and EG-DMA used per 100 mL of
monomer for that composition and 𝜌𝐸𝐺−𝐷𝑀𝐴 is the density of the ethylene glycol-dimethacrylate
(g/mL). 𝐷𝐵𝑓 was calculated because as the volumetric ratio of EG-DMA to MMA (mL:mL)
increased between compositions, so did the number of theoretical monomer double bonds. As
mentioned earlier, the heat generated during the breaking of a one MMA double bond is
indistinguishable to that of one EG-DMA double bond breaking (18). This led to the assumption
that the total theoretical heat produced is proportional to the amount of double bonds present. The
total theoretical heat (100% conversion) produced per mole of MMA is 56.9 kJ (21, 30). The
conversion of each sample was found by Equation 4.7.7.
𝑋 = 𝐷𝐵

𝐻𝑐𝑢𝑟𝑖𝑛𝑔

𝑓 ∗56.9𝑘𝐽/𝑚𝑜𝑙

(4.7.7)

where X is the fractional monomer conversion. The residual monomer (RM) concentration was
found using Equation 4.7.8.
𝑅𝑀 = (1 − 𝑋) × 100%

(4.7.8)

The glass-transition temperature was measured using the DSC analysis software (TA Analysis) at
the inflection point in the second heating cycle (Figure A.2). All compositions were tested in
triplicate (n=3) and the fractional monomer conversion, residual monomer concentration, total heat
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generated and glass transition temperatures were reported as an average with corresponding
standard deviations.
4.8 Optical microscopy and SEM observations
Optical imaging and SEM analysis in high magnification were performed for fracture surface
analysis. Fracture propagation is usually indicated by a series of semi-circles originating from one
central point on the tension surface. Samples were imaged directly in the digital optical microscope
(Hirox, KH-8700) using a variety of magnifications before SEM preparation. For the preparation
of SEM imaging, samples were dried overnight in a desiccator, gold sputtered (Denton Vacuum,
Desk II) for 45 seconds and then transferred to the SEM viewing chamber (JEOL, 5600).
4.9 Statistical analysis
Statistical analysis was performed across all experiments. One-way ANOVA was applied with
simple effect and Tukey’s post hoc comparisons were performed for samples displaying a
significant interaction. Significant differences between groups was taken at p<0.05 and Tukey’s
comparisons were statistically significant if sample sets didn’t share a common grouping. Linear
and second-order quadratic fits were applied to data using SigmaPlot 6.0 (Systat) and R2 values
were reported as a measure of fit for data sets that appeared to show a correlation.
5. Results
Appendix C contains data result tables for all experiments as a function of EG-DMA content.
5.1 Exothermal characteristics of modified cements containing EG-DMA
The effect of the substitution of methyl methacrylate monomer for ethylene glycoldimethacrylate on exothermal behavior of two-solution bone cements was assessed and
compared to the standard TSBC previously characterized by Hasenwinkel et al. (3) at a fixed
BPO:DMPT molar ratio of 1. Figures 5.1.1 and 5.1.2 show the exothermal characteristics of
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Figures 5.1.1 and 5.1.2: Maximum polymerization temperatures and setting times for TSBC
and TSBC samples containing EG-DMA. Setting time and maximum polymerization
temperatures are plotted as a function of EG-DMA vol%. Sample sets (n=3) that are
significantly different (p<0.05) are indicated by an asterisk (*) and a line that spans between
the significantly different sample sets.
TSBCs modified with EG-DMA performed in the standard ASTM mold. There was not a
significant change (p<0.05) in maximum polymerization temperature between the control
composition (0EGDMA, 83.43°C) and all modified compositions. 25EGDMA’s maximum
polymerization temperature was significantly lower (p<0.05) than 5EGDMA, 15EGDMA and
20EGDMA’s maximum polymerization temperature. 15EGDMA’s maximum temperature was
significantly higher (p<0.05) than 2.5EGDMA and 25EGDMA. There were no noticeable trends
between EG-DMA concentration and maximum polymerization temperature (Figure 5.1.1). The
highest temperatures recorded were in excess of 90°C (15EGDMA, 20EGDMA) and the lowest
recorded temperatures were below 78°C (2.5EGDMA, 25EGDMA). There was also no
significant difference (p<0.05) in any composition’s setting time (Figure 5.1.2) when compared
with the control cement.
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5.2 Fracture toughness analysis
Substitution of MMA with EG-DMA
was assessed across all compositions
during fracture toughness analysis
(Figure 5.2.1). Sample sets (n=4) were
tested under the same laboratory
conditions and all samples for a
particular composition set were stored for
the same amount of time before testing. All
samples in one set were tested the same day.
There were no compositions that showed a
significant increase (p<0.05) in fracture

Figure 5.2.1: Critical stress intensity factor (KIC)
plotted as a function of EG-DMA vol%. Sample
sets (n≥4) that are significantly different
(p<0.05) are indicated by an asterisk (*).
Samples containing 0, 2.5 and 5 vol% EG-DMA
are not significantly different from each other,
and samples containing 15-25 vol% EG-DMA
are also not significantly different from each
other.

toughness from the control, but compositions containing higher than 5 vol% EG-DMA
(10EGDMA, 15EGDMA, 20EGMDA, 25EGDMA) showed a significant decrease (p<0.05) in
fracture toughness. 10EGDMA had a significantly (p<0.05) lower fracture toughness than
samples with a lower EG-DMA concentrations (0EGDMA, 2.5EGDMA, 5EGDMA).
10EGDMA also had a significantly higher fracture toughness (p<0.05) than sample sets
containing higher concentrations of EG-DMA (15EGDMA, 20EGDMA, 25EGDMA).

Increasing the EG-DMA concentration from 0 to 5 vol% EG-DMA displayed a rise in fracture
toughness, but not significantly higher than the control TSBC. In compositions higher than 5
vol% EG-DMA, there was a sharp decrease to below half the fracture toughness of the control
(Figure 5.2.1). The maximum critical stress intensity factor (KIC) occurred at 5 vol% EG-DMA
(1.6055 MPa√m) and 25 vol% EG-DMA had the lowest critical stress intensity factor at 0.2584
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MPa√m. 0EGDMA and 25EGDMA sample sets only contained 4 samples and all other
compositions had 5 samples per set.
5.3 Flexural properties
Figures 5.3.1-5.3.4 illustrate the flexural properties of cements containing EG-DMA referenced
against the control TSBC for sample sets (n=5). 10EGMDA displayed a significantly higher
(p<0.05) maximum flexural strength (peak stress reached during plastic deformation, maximum
value of Equation 4.5.1) than the control (0EGDMA), 2.5EGDMA, 20EGDMA and 25EGDMA.
The sample sets 5EGDMA, 10EGDMA and 15EGDMA had significantly higher (p<0.05) peak
flexural strength than 2.5EGDMA, 20EGDMA and 25EGDMA. 5EGDMA and 15EGDMA had
a significantly (p<0.05) higher peak flexural strength than 2.5EGDMA, 20EGDMA and
25EGDMA (Figure 5.3.1). The maximum flexural strengths ranged from 114.84 MPa
(10EGDMA) to 84.17 MPa (25EGDMA). The maximum flexural strength was also fit to a
second-order polynomial with a measure of fit (R2) of 0.7442.

The bending modulus (Figure 5.3.3) (slope of the linear region of elastic deformation) was
calculated using Equation 4.5.2 for all compositions within the elastic region of the stress vs.
strain plots. There were no compositions with a significantly higher bending modulus (p<0.05)
than the control (2.8022 GPa), but 25EGDMA had a significantly (p<0.05) lower bending
modulus (2.4892 GPa). Samples containing 0-20 vol% had a significantly higher bending
modulus than 25 vol% EG-DMA with the highest bending modulus occurring at 3.0431 GPa
(10EGDMA). 5EGDMA, 10EGDMA and 15EGDMA had significantly higher (p<0.05) bending
moduli than 2.5EGDMA and 25EGDMA. The bending modulus was also fit to a second-order
polynomial with an R2 value of 0.6928.
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Figures 5.3.1-5.3.4: Maximum flexural strength (5.3.1), yield strength (5.3.2), bending
modulus (5.3.3) and strain-to-failure (5.3.4) plotted as a function of EG-DMA vol%. Sample
sets that are significantly different (p<0.05) are indicated by an asterisk (*) and a line that
spans between both sample sets. Bent lines with an asterisk indicate a grouping of
significantly different sample sets.
The yield strength (Figure 5.3.2) was assessed at the point at which plastic deformation began
(0.2% strain offset from elastic region) and elastic deformation ended. Plastic deformation is
synonymous with non-recoverable deformation in the material (24). There were no significant
differences between the control and samples containing 5-25 vol% EG-DMA, with 2.5 vol% EGDMA samples being significantly weaker (p<0.05) than all other sample sets (46.87MPa). The
highest measured yield strength for a sample set was at 15vol% EG-DMA (71.82 MPa).
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There were no significant differences in the strain-to-failure data, however it should be noted that
the test’s limit was set at 10% strain (Figure 5.3.4). All of the control samples fractured before
the upper threshold of the test and sample sets containing 2.5, 5, 20 and 25 vol% EG-DMA did
not fracture. This would imply that those compositions have a higher average strain-to-failure
limit than 10%. All EG-DMA samples exceeded ISO 5833:2002 Requirements for Bone
Cements for bending modulus (minimum of 1.8 GPa) and maximum flexural strength (minimum
of 50 MPa) (31). The mechanical properties of the control cement were similar to those
previously reported in the Hasenwinkel lab (14).
5.4 Conversion, exothermic heat, concentration of residual monomer and glass-transition
temperature
Figure 5.4.1 shows the different fractional
monomer conversions for increasing
concentrations of EG-DMA in the twosolution bone cement system. From Figure
5.4.1, it can clearly be seen that the control
reaches the lowest conversion rate after 59
minutes with all compositions containing
EG-DMA reaching higher levels of
conversion. The isothermal test ran for 60

Figure 5.4.1: Fractional monomer conversion
after being held 59 minutes isothermally.
Groups connected with a line overhead and an
asterisk (*) are significantly different from
one another (p<0.05).

minutes; however, a negative heat flow was
achieved after the first jump step (Table 4.6.1 and Figure A.1) and this data was removed and
integration began once a positive heat flow (above 0 W/g) was recorded. Therefore, a full 60
minutes of data was not obtained for any composition and the nearest whole number was used
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for final conversion calculations across all samples (59 mins). Analyzing fractional conversion of
monomer at 59 mins, there is a significant increase (p<0.05) in conversion for samples
containing 2.5 vol%, 10 vol%, 15 vol% and 20 vol% EG-DMA from the control with a peak
conversion at 20 vol% EG-DMA (89.81%). The lowest conversion of the EG-DMA samples
occurred at 79.88% (25EGDMA), also higher than the control (73. 98%). 20EGDMA was
significantly (p<0.05) higher than the control, 5EGDMA and 25EGDMA. Looking at Figure
5.4.5 and A.1, it would appear that the initial curing reaction happens within the first 10 minutes
with the remaining 50 minutes accounting for less than 10% of the samples conversion. The heat
of reaction (Figure 5.4.2) for all compositions containing EG-DMA was significantly higher
(p<0.05) than the control. 20EGDMA had a significantly higher heat of reaction than
2.5EGDMA, 5EGDMA and 25EGDMA. The concentration of residual monomer is directly
related to the fractional monomer conversion.

2.5EGDMA, 10EGDMA, 15EGDMA and
20EGDMA samples had significantly less
(p<0.05) residual monomer (Figure 5.4.3)
than the control (26.02%) with 20EGDMA
(10.19%) having the least amount of
residual monomer of the samples
containing EG-DMA. 25EGDMA and
5EGDMA had lower residual monomer
concentrations than the control, but not to a
significant effect (p<0.05). The control
sample’s fractional conversion and residual

Figure 5.4.2: Exothermic heat of reaction as a
function of EG-DMA vol%. Groups connected
with a line overhead and an asterisk (*) are
significantly different from one another
(p<0.05). Bent lines signify a grouping of
compositions.
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monomer concentration were consistent with previously reported data in the Hasenwinkel lab
(14). The glass-transition temperature (Figure 5.4.4) was measured using the second nonisothermal scan of the material after all residual monomer had been driven to conversion (Figure
A.2). There was no significant difference (p<0.05) between samples containing EG-DMA and
the control. There was a significant increase (p<0.05) in the glass-transition temperature between
2.5EGDMA and 25EGDMA, and glass-transition temperature showed a positive correlation with
increasing EG-DMA content. Crosslinking has been shown to increase the glass-transition
temperature in polymeric materials (24) and this could indicate an increase in crosslinking
between polymerized samples containing EG-DMA. Figure A.1 displays heat flow vs. time for
the duration of the experiment using the control TSBC with the different sections of the method
file labeled. Figure 5.4.5 displays the fractional monomer conversion data for all formulations.

Figures 5.4.3-5.4.4: Residual monomer concentration (5.4.3) and glass-transition temperature
(5.4.4) plotted as a function of EG-DMA vol%. Sample sets that are significantly different
(p<0.05) are indicated by an asterisk (*) and a line that spans between both sample sets.
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Figure 5.4.5: Fractional conversion of all compositions during the isothermal DSC
experiment. The control resulted in the lowest amount of fractional monomer conversion and
20 vol% EG-DMA produced the highest fractional conversion after 59 minutes.

5.5 Viscosity analysis
Viscosity measurements were taken across all shear rates that were measurable in triplicate for
each composition. Measurements were recorded 10 times across 5 minutes, every 30 seconds
after viscosity stabilization. When switching between shear rates, the material needed time to
stabilize at the new RPM before accurate readings could be taken. This was signaled when the
viscometer stopped blinking. The DV-E rheometer recorded torque in addition to viscosity, and
torque increased with increasing shear rates. Readings were recorded after the torque measured
above 10% and ceased once the viscosity and torque readings measured “EEEE cP” and “EEEE
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%” respectively. This was representative of torque over 100%. There was only one shear rate
(0.8 s-1) where all compositions were recordable. The control composition didn’t produce enough
torque for accurate readings below this shear rate, and 25 vol% EG-DMA produced torque
greater than 100% (EEEE %) above this shear rate. At a shear rate of 0.8 s-1, compositions
containing 5-25 vol% EG-DMA were significantly higher (p<0.05) in viscosity than the control.
25EGDMA had a significantly higher (p<0.05) viscosity than all other samples, 20 EGDMA had
a significantly (p<0.05) higher viscosity than 2.5EGDMA, 5EGDMA, 15EGDMA and the
control. 10EGDMA had a significantly higher (p<0.05) than 2.5EGDMA, 15EGDMA and the
control. 15EGDMA and 5EGDMA were significantly higher (p<0.05) than 2.5EGDMA and the
control (Figure 5.5.1). Compositions 2.5-20 vol% EG-DMA all had viscosities significantly
higher (p<0.05) than the control for shear rates greater than 0.8 s-1 (1, 1.2, 1.6, 2, 2.4 s-1).
25EGDMA was significantly higher (p<0.05) than all other concentrations at all measurable
shear rates. At higher shear rates (2 s-1, 2.4 s-1), 20EGDMA had a significantly higher (p<0.05)
viscosity than all other measurable
concentrations. Across all shear
rates, 2.5EGDMA is significantly
lower in viscosity (p<0.05) than
all other EG-DMA compositions.
For all shear rates it followed the
basic correlation that the higher
the EG-DMA concentration, the
higher the measured viscosity
(Figures 5.5.2-5.5.9) with a few

Figure 5.5.1: Viscosity measurements as a function of
EG-DMA vol% at a fixed shear rate of 0.8 (1/s). Groups
connected with a line overhead and an asterisk (*) are
significantly different from one another (p<0.05). Bent
lines signify a grouping of compositions.
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exceptions. For example at 0.4 s-1, 2.5EGDMA and 15EGDMA are significantly lower (p<0.05)
in viscosity than all other EG-DMA containing compositions. At 0.4 s-1, 5EGDMA is
significantly (p<0.05) higher than 20EGDMA. Excluding the few exceptions, these relationships
can be inferred because PMMA beads do not dissolve in EG-DMA, and therefore the PMMA to
MMA ratio increases with increasing EG-DMA concentrations. The increase in density of the

Figure 5.5.2: Viscosity profiles for each composition across all recordable shear rates. Each
shear rate was tested in triplicate.
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Figure 5.5.3-5.5.9: Viscosity profiles for
individual compositions with a linear
regression fit. Control (5.5.3), 2.5 vol%
(5.5.4), 5 vol% (5.5.5), 10 vol% (5.5.6),
15 vol% (5.5.7), 20 vol% (5.5.8) and 25
vol% (5.5.9). The negative slope indicates
a shear thinning behavior. The closer the
slope is to zero, the more the material
behaves like a Newtonian fluid and the
less it is influenced by shear rates (14).
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PMMA/MMA slurry decreases the ability of the material to be deformed and flow freely.
Replacing equal volumes of MMA (0.94 g/mL) with EG-DMA (1.051 g/mL) will increase the
viscosity of the resulting material. All viscosities were plotted on logarithmic-logarithmic scale
and fitted to a linear regression. The slopes of the regression lines in Figures 5.5.3-5.5.9 give the
type and degree of non-Newtonian flow, in which a zero slope would indicate Newtonian
behavior (14). All the slopes reported are negative signifying shear thinning behavior for all
compositions tested. While the control cement was significantly lower in viscosity (p<0.05) at all
shear rates than samples containing 5-25 vol% EG-DMA, it did have a more negative slope
demonstrating more pseudoplasticity (14). This would imply that the EG-DMA samples are less
sensitive to shearing forces. The viscosities reported for the control cement were similar to those
previously reported in the Hasenwinkel lab (14).
5.6 Scanning electron microscopy and optical imaging
SEM micrographs (Figures 5.6.1-5.6.3)
revealed a ripple deformation along the
fracture surface in samples containing EGDMA, indicating a change in the plastic
deformation mechanism in comparison to the
control. The control sample micrographs
contained concentric artifacts that originated
from one fracture point, representing the site
of crack formation and subsequent
propagation. These morphologies are
consistent with those previously reported (3).

Figure 5.6.1: SEM micrograph of the control
sample fracture site during three-point bend
tests. Notice the concentric rings that originate
from the point of failure. The smooth surface
between the rings represents a fast fracture
mechanism.
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Figures 5.6.2-5.6.3: Cement containing 25 vol% EG-DMA, fractured from three point bend
tests. Observe the ripple formation along the fracture edge that is present in the above
micrographs, but absent from control samples. It is believed this is a result of the plastic
deformation mechanism and higher strain-to-failure values.
This phenomenon is less prominent in EG-DMA samples with a rippled ridge along the fracture
surface more visible. These morphological changes could be a direct result of the substitution of
MMA for EG-DMA, causing a change in the bond stretching and deformation (15). Imaging
using the high magnification optical microscope revealed a uniformity in these morphological
changes across the entire fracture surface. A different fracture pattern than the control was

Figures 5.6.4-5.6.5: Digital optical images of TSBC fracture surfaces with 10 vol% EG-DMA.
The point of fracture and surface is different than the control samples (Figures B.3-B.4). It
should also be noted that these samples fractured into several pieces whereas the control
samples fractured into two pieces.
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observed (Figures 5.6.4-5.6.5) once the surface was imaged at lower magnifications. These
images revealed a larger scale version of the ridges seen in the SEM micrographs originating
from the point of fracture as well as along the edge of the sample. Also, where the surfaces of the
control samples were relatively flat, the EG-DMA samples produced surfaces with many
protruding edges and points. Additional SEM micrographs and supplementary optical imaging
pictures can be found in Appendix B.

6. Discussion
Substitution of methyl methacrylate (MMA) monomer for ethylene glycol-dimethacrylate (EGDMA) crosslinker was observed to increase viscosity of the two-solution formulation while
improving thermal and mechanical characteristics for certain concentrations of EG-DMA. These
compositions appear to improve upon some of the setbacks of commercial cements for the
treatment of implant augmentation and fixation. The higher viscosity in the modified TSBCs
containing EG-DMA can be attributed to a higher PMMA to MMA ratio, increasing the
resistance to flow and deformation. Improved mechanical properties of the modified TSBCs can
be credited to EG-DMA crosslinks between adjacent PMMA chains in the polymerized sample.
The effect of EG-DMA on exothermal and setting properties at increasing concentrations of EGDMA was evaluated using the standard ASTM F451 mold (25). As previously mentioned, there
was no significant difference (p<0.05) in the maximum polymerization temperature between the
control TSBC and the modified compositions. This could be expected because there are offsetting variables with increasing EG-DMA content. Referencing Table 4.1.1, the moles of
monomer decreased with increasing EG-DMA content but the available double bonds present for
free radical polymerization increased. EG-DMA molecules are larger in molecular weight and
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density than MMA molecules, therefore, replacing MMA molecules with the larger EG-DMA
molecules occupying the same volume gives lower total moles. The amount of double bonds
slightly increases because although EG-DMA molecules are almost twice are large as MMA
molecules, 198.22 g/mol to 100.121 g/mol respectively, EG-DMA has twice as many double
bonds. Thus, EG-DMA contains slightly more double bonds per unit mass, and by referencing
the density, per unit volume as well. Replacing the same volume of MMA with EG-DMA gives a
slight increase in total number of double bonds present. We expected polymerization
temperatures and heat generated to remain consistent across samples because while decreasing
the moles present would decrease the overall heat generated, increasing the amount of double
bonds would increase the overall heat generated. All samples had a significantly (p<0.05) higher
heat of reaction and these changes could be attributed to the high reactivity of EG-DMA
molecules, as previously mentioned by Zuk et al. (22). The increased heat of reaction can help
explain the significant differences in polymerization conversion achieved by EG-DMA samples.
The heat of reaction is directly related to the number of MMA and EG-DMA carbon-carbon
double bonds broken, therefore the more heat released, the higher the conversion rate.
It was determined that samples containing 2.5-20 vol% EG-DMA had a significantly higher
(p<0.05) conversion rate with a significantly (p<0.05) lower residual monomer concentration
after 59 minutes of isothermal-DSC. This further (22) confirms that the EG-DMA molecules are
more reactive than MMA molecules in this environment. The amount of the double bonds
present in the highest concentration of EG-DMA (25 vol%) is only 3% higher than the control
TSBC. The conversion rates measured are much higher than a 3% increase for EG-DMA
samples, indicating that the EG-DMA molecules are more reactive than the MMA monomer
molecules. It should be noted again that the heat released by a carbon-carbon double bond in an
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MMA molecule is indistinguishable from an EG-DMA molecule, and thus the conversion was
taken as a percentage of all monomer molecules theoretically present (18).
Viscometry tests were performed at every measurable shear rate across all compositions. There
was an observable trend across the compositions that as EG-DMA concentration increased, so
did the viscosity at any given shear rate. This was expected due to the substitution of MMA for
EG-DMA. EG-DMA has a higher viscosity than MMA, and PMMA resin is not soluble in EGDMA monomer. Therefore, the PMMA/MMA slurry density increased with EG-DMA content
and the resulting mixtures had significantly (p<0.05) greater viscosities. The EG-DMA
compositions have a more stable viscosity across all shear rates (slope of the regression line)
which allows for a consistent application of the material no matter the applied pressure. This is
commercially advantageous over other high viscosity cements because of its consistency,
creating less variation between samples and applications (2, 5).
The mechanical properties of the EG-DMA samples were either significantly equivalent (p<0.05)
or superior to the TSBC control for maximum flexural strength, bending modulus, yield strength,
and fracture toughness, depending on the composition. Some compositions displayed a ‘dropoff’ in mechanical integrity past a certain concentration of EG-DMA. Increasing the amount of
monomer available has been proven to increase the probability of longer polymerized chains and
higher molecular weights in the set cement (3), and higher molecular weight polymers have been
proven to possess superior mechanical properties than lower molecular weight polymers (24).
The maximum flexural strength (Figure 5.3.1) increased with increasing EG-DMA content up to
10 vol% before the strength decreased. This trend follows a second order polynomial with an R2
value of 0.7442. This would indicate that up to 10 vol%, the EG-DMA crosslinker has more of
an effect on the strength of the material than the decreasing MMA content. After 10 vol%,
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decreasing the amount of MMA available appears to dominates mechanical properties regardless
of crosslinker concentration. The bending modulus increases with increasing EG-DMA content
up to 10 vol% and then decreases with increasing EG-DMA concentrations. The bending
modulus follows a similar polynomial trend as seen in the maximum flexural strength data with
an R2 value of 0.6929. The yield strength has less of a noticeable trend with increasing EG-DMA
content. Yield strength increased up to 15 vol% EG-DMA, then decreased at 20 vol% and
recovered some strength at 25 vol% EG-DMA.
During fracture toughness tests, the 𝐾𝐼𝐶 increased with increasing EG-DMA content up to 5
vol% EG-DMA at about 1.6 MPa*m1/2 but then significantly fell off at 10 vol% to below 0.8
MPa*m1/2 and decreased exponentially after that up to the maximum EG-DMA concentration of
25 vol%. We predicted the fracture toughness of the material to increase with increasing
crosslinker content, however similar to other mechanical properties, decreasing MMA content
dominates the crosslinker affect a certain point. Deb et al. (10) reported that mechanical
properties of acrylic bone cements based on poly(ethylmethacrylate)-n-butylmethacrylate)
(PEMA) improve with the addition of crosslinking agents such as EG-DMA and triethylene
glycol-dimethacrylate (TEG-DMA) at low concentrations (2.5-5 wt/wt %) but steadily decrease
when the concentrations are increased. Yang et al (19) reported similar mechanical trends using
tricalcium phosphate (TCP), HEMA and EG-DMA within an acrylic bone cement system. We
attribute these similar trends to molecular-level changes within the material. Weak van der
Waal’s forces within the PMMA matrix are being replaced with stronger physical covalent bonds
as crosslinking increases. At higher crosslinker concentrations, ‘submicro cracks’ (19) develop
within the material caused by internal stresses as a result of shrinkage or thermal changes (32).
These micro cracks are then observed in post hoc SEM imaging (Figure 6.1). The rougher EG-
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DMA surfaces are due to the crack front interacting with a greater number of micro cracks within
the material. These interactions cause crack arrest or out-of-plane crack deflection. This results
in larger fracture surface area and micro craters/volumes where mode I opening does not apply
(33), both of which increase 𝐾𝐼𝐶 values. Lednicky and Pelzbauer (34) proposed that PMMA
based cements undergo a coalescence fracture mechanism between primary and secondary crack
fronts. The secondary crack fronts are initiated at the micro volumes within the material and
when the secondary crack front meets the primary crack front, the fracture mechanism increases
in speed and decreases in magnitude. This is in agreement with the higher concentrated EGDMA samples tested.
SEM micrographs confirmed a different fracture mechanism presented in the EG-DMA samples.
During three-point bend tests, fractured TSBC fragments produced two pieces with mirrored
A

B

Figure 6.1: Micrographs of a three-point bend sample (A) and fracture toughness sample (B)
displaying high magnified fractured surfaces. (A) 10EGDMA and (B) 2.5EGDMA samples
display rough surfaces with micro cracks, ridges and small craters along the surface
fracture surfaces. The EG-DMA samples that broke fractured in more than two pieces with
varying fracture surfaces and morphology. The TSBC fracture surface was characterized by
concentric elliptical zones originating from the bottom surface subjected to tension. The crack
continues to propagate radially until it reaches the other edge subjected to compression from the
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crosshead. EG-DMA samples contained several small ridges or “tufts” (10 µm wide) and little
craters along the fracture surface that are indicative of high levels of plastic deformation (Figure
6.2). This indicates that the PMMA was subjected to large amounts of plastic strain before
failure (32). EG-DMA samples had
higher strain-to-failure values and by
association, larger plastic deformation
regions than the TSBC control. This
conforms with Min et al.’s molecular
dynamic simulations that crosslinking
PMMA chains with EG-DMA
molecules increases the ductility due
to the increased alignment and
resistance to deformation along the

Figure 6.2: SEM micrograph of 5 vol% EG-DMA at
1,200X magnification of the fracture edge. Micro
troughs are visible along the boundary of the fracture
surface (Three-point bend sample).

carbon backbone (15).
7. Conclusion
The results presented in this work demonstrate the thermal, mechanical & viscous properties of
crosslinked two-solution bone cement formulations. Certain compositions provided superior
mechanical integrity while others demonstrated improved monomer conversion or lower
exothermal properties. Samples containing 5-10 vol% EG-DMA demonstrated the greatest
improvement in mechanical properties, while those with 15-20 vol% had the highest levels of
monomer conversion with the lowest amount of residual monomer. Sample sets containing 2.5,
5, 20 and 25 vol% EG-DMA did not fracture during three-point bend tests, indicating an increase
in ductility from the control TSBC. 5EGDMA had the largest fracture toughness, 10EGDMA
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had the greatest maximum flexural strength and bending modulus. 15EGDMA had the highest
yield strength, and 20EGDMA had the highest level of monomer conversion. Samples containing
25 vol% EG-DMA had significantly lower polymerization temperatures while all compositions
produced a significantly greater amount of heat during the initial polymerization. All modified
samples expressed an increase in viscosity, with a positive correlation between increasing EGDMA content and increasing viscosity. 5EGDMA and 10EGDMA would be the best candidates
for an alternative solution used in load bearing applications like total arthroplasties of the lower
extremities due to their superior mechanical integrity when compared to the control TSBC. For
uses that require minimalization of residual monomer, 20EGDMA is the most suitable
formulation. One possible use could be vertebroplasty where reducing the amount of monomer in
the cured sample contributes to pain relief (13). Overall, EG-DMA proved to have an appreciable
effect on the characterization of the TSBC.

8. Future Work
The results presented in this work provide a detailed characterization involving the substitution
of MMA for EG-DMA. A continuation of this work would include compositions with 5-20 vol%
EG-DMA as these formulations demonstrated improvement in mechanical and thermal
properties. There have been recent attempts to modify PMMA based cements with biodegradable
polymers and osteoconductive bioceramics for fracture fixation and bone regeneration. We
believe that the EG-DMA formulations will provide a good platform for future work involving
these materials for similar purposes.
Poly(DL-lactic-co-glycolic acid) (PLGA) is a synthetic copolymer that degrades by
nonenzymatical hydrolysis of the carbon-backbone ester linkages (35, 36). It has been found that
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the incorporation of PLGA in PMMA/MMA bone cements can create controlled porosity via
bulk and surface degradation of the PLGA microsphere constituent (37). Additionally, PLGA
degradation in calcium phosphate/PLGA scaffolds did not generate an immune response after 12
weeks in vivo and histomorphometric analysis confirmed new bone deposition within degraded
scaffolds (36).It has also been found experimentally in the Hasenwinkel lab that PLGA is soluble
up to 200 wt% (g/mL) in MMA. This is an attractive feature because by adding greater
concentrations of polymer to the monomer solution, we are reducing the amount of PMMA in
the final cured sample. This reduces the amount of material that cannot be degraded.
Calcium sulfate is also an osteoconductive radiopaque inorganic material with faster (4 weeks)
degradation characteristics than calcium phosphate (1 year) (39). Calcium phosphate and calcium
sulfate cements are known to be brittle, and recent attempts have been made to incorporate these
radiopaque additives with acrylic based cements (40). Barium sulfate, a crystalline inorganic
radiopaque material, when added to Simplex cement decreases the ultimate tensile strength and
fracture toughness of the cured cement (40). Deb et al. (32) added barium sulfate particulate to
acrylic bone cement containing small amounts of methacrylate-based crosslinker and showed an
increase in tensile strength and ductility. This was attributed to the barium sulfate acting as a
filler in the more flexible crosslinked network. We hypothesize that the addition of PLGA and
calcium sulfate in the EG-DMA modified cement formulations will provide a similar effect as
described (32, 40).
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Appendix A- DSC output file

Figure A.1: DSC exotherm of the TSBC control. Isothermal and non-isothermal stages are
marked as well as the initial curing peak and residual monomer peak. Notice the lack of
residual monomer peak in the second heating scan.

Figure A.2: Heat flow vs. temperature for the control TSBC. The glass-transition temperature
was measured using the inflection point during the second heating scan. DSC exotherms
confirmed the absence of the residual monomer peak, making the glass-transition temperature
measurement possible.
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Appendix B- SEM and digital optical microscope images
B.1

B.2
B.1

B.3

B.4

B.2

B.2

B.1

B.1

B.5

B.6

B.2

B.2

B.1

B.1

Figures B.1-B.6: Fracture surfaces of the TSBC control (B.1, B.2) showing the concentric
rings originating from the fracture surface. Digital optical images of the control sample
immediately after fracture (B.3, B.4). B.5 and B.6 are high magnification images of the
fracture surface of a sample containing 5 vol% EG-DMA. There are micro-scaled ridges and
microcracks as a direct result of plastic deformation.
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B.7

B.8

B.2

B.2

B.1

B.1

B.9

B.10

B.2
B.1

B.11
B.2
B.1

B.12
B.2
B.1

Figures B.7-B.12: Three-point bend fracture surfaces of TSBC with 10 vol% EG-DMA (B.7,
B.8), 15 vol% EG-DMA (B.9, B.10) and 20 vol% EG-DMA (B.11, B.12). Ridges as a result
of plastic strain and deformation (B.9, B.11) of 15EGDMA. Zoomed in micro-ruffles (B.12)
of the same sample.
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B.13

B.14

B.2

B.2

B.1

B.1

B.15

B.16

B.2
B.1

B.17

B.18

B.2
B.1

Figures B.13-B.18: Fracture toughness test surfaces of the TSBC with 2.5 vol% EG-DMA
(B.13), 5 vol% EG-DMA (B.14) and 20 vol% EG-DMA (B.15). Ridges as a result of plastic
strain and deformation of 15EGDMA (B.16). Zoomed in micro-ruffles of the same sample.
B.17 displays the mico-craters along the fracture surface in 25EGDMA. The fracture surface
edge (B.18) of a fractured 25EGDMA sample.
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Appendix C- Experimental data for all experiments with standard deviations (SD)
Table C.1: Exothermal and mechanical properties of TSBCs modified with EG-DMA

Maximum polymerization
temperature (°C)
Setting time (min)
Strain-to-failure (%)
Fracture toughness (MPa*m½)
Maximum flexural strength (MPa)
Bending modulus (GPa)
Yield strength (MPa)
Heat of reaction (kJ/mol)
Fractional monomer conversion
Fractional residual monomer
Glass-transition temperature (°C)

Control

2.5EGDMA

5EGDMA

10EGDMA

15EGDMA

20EGDMA

25EGDMA

83.43
(2.25)
5.23
(0.38)
7.62
(2.04)
1.3588
(0.08)
97.86
(5.09)
2.80
(0.10)
62.76
(2.67)
42.10
(2.13)
0.7398
(0.04)
0.2602
(0.04)
104.07
(0.87)

77.59
(3.36)
5.31
(0.26)

88.74
(5.09)
4.64
(0.07)

73.21
(2.58)
4.75
(0.36)

10 (0)

10 (0)

10 (0)

1.433
(0.27)
90.01
(4.30)
2.57
(0.09)
46.87
(9.28)
47.56
(1.05)
0.8332
(0.02)
0.1668
(0.02)
102.99
(1.20)

1.6055
(0.18)
110.31
(11.70)
2.90
(0.22)
68.62
(7.45)
46.62
(0.77)
0.8141
(0.01)
0.1859
(0.01)
104.32
(1.14)

92.56
(3.24)
4.92
(0.24)
8.78
(1.51)
0.4239
(0.06)
108.26
(6.35)
2.93
(0.13)
71.82
(2.78)
48.34
(2.81)
0.8333
(0.05)
0.1667
(0.05)
104.48
(0.21)

91.67
(4.85)
5.43
(0.15)

10 (0)

83.26
(9.79)
4.72
(0.47)
9.01
(1.97)
0.7800
(0.07)
114.84
(8.77)
3.04
(0.16)
69.35
(4.76)
49.14
(1.15)
0.8525
(0.02)
0.1475
(0.02)
103.46
(0.19)

0.3092
(0.02)
93.25
(6.25)
2.81
(0.14)
63.32
(2.60)
52.43
(0.63)
0.8981
(0.01)
0.1019
(0.01)
105.36
(0.82)

0.2584
(0.06)
84.17
(3.33)
2.49
(0.11)
67.91
(4.23)
46.92
(1.35)
0.7988
(0.02)
0.2012
(0.02)
106.27
(1.94)

Table C.2: Viscosity characteristics of TSBCs modified with EG-DMA
Shear
Rate
(1/s)

0.4
0.6
0.8
1.0
1.2
1.6
2.0
2.4

Control
(Pa·s)

2.5EGDMA
(Pa·s)

5EGDMA
(Pa·s)

10EGDMA
(Pa·s)

15EGDMA
(Pa·s)

20EGDMA
(Pa·s)

25EGDMA
(Pa·s)

1137 (60.88)
1029 (59.91)
903.5 (48.47)
751.8 (56.43)
636.8 (65.65)
566.4 (93.38)

1606 (203.2)
1324 (160.1)
1253 (227.0)
1204 (291.4)
1199 (319.6)
1042 (226.7)
927.1 (157.1)
860.1 (132.6)

2366 (567.9)
1792 (88.24)
1672 (90.00)
1617 (86.08)
1536 (114.9)
1364 (145.1)
1225 (173.5)
1126 (192)

2152 (274.9)
1850 (120.5)
1776 (112.4)
1702 (103.1)
1672 (129.6)
1583 (162.1)
1463 (158.9)
1330 (152.1)

1716 (224.2)
1588 (230.9)
1581 (178.0)
1440 (156.5)
1426 (129.9)
1351 (131.1)
1304 (120.9)
1198 (128.4)

2032 (99.67)
1897 (166.3)
1822 (151.0)
1791 (151.9)
1745 (125.1)
1652 (94.90)
1582 (96.64)
1482 (54.46)

3689 (270.1)
4101 (583.0)
3103 (335.1)
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